After Hours Summary: HEI +6%, PAHC -1% following earnings/guidance, AFMD +147% on Genentech collaboration newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: HEI +5.8%
Companies trading higher in after hours in reaction to news: AFMD +146.9% (announces collaboration with Genentech to develop novel NK cell engager-based immunotherapeutics for multiple cancer targets; Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 bln), BRKS +14.9% (to sell its semiconductor cryogenics business to Atlas Copco for $675 mln in cash), LSCC +6% (appoints Jim Anderson CEO effective September 4), TTPH +5.5% (announces FDA approval of XERAVA for complicated intra-abdominal infections), ALNY +3.6% (following AKCA / IONS CRL news), ICHR +1.8% (CFO disclosed the purchase of 5.2K shares), AMD +1.3% (names Saeid Moshkelani as SVP of Client Compute Group; Darren Grasbya named SVP of global Computing and Graphics sales, replacing Jim Anderson who leaves to pursue other opportunities)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: MITK -4.1% (CEO and CFO will be departing; co reaffirms full-year guidance), PAHC -0.9%
Companies trading lower in after hours in reaction to news: AKCA -24.1% and IONS -14.3% (Akcea Therapeutics and Ionis receive Complete Response Letter for WAYLIVRA from FDA), WMGI -4.3% (announces $440 mln stock offering from existing shelf registration)
![]()